Detailed analysis of the CD11b + myeloid populations revealed that pro-inflammatory M1-like and MHCII-CD206- cells, associated with anti-tumor immune activity remained relatively constant as a proportion of F480+ cells during the course of tumorigenesis. The gene discussed is MRC1; the disease is neoplasm.